Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 2
1984 2
1985 1
1986 7
1987 5
1988 7
1989 7
1990 8
1991 7
1992 9
1993 15
1994 13
1995 21
1996 13
1997 9
1998 6
1999 8
2000 7
2001 1
2002 3
2003 2
2004 4
2005 4
2006 2
2007 3
2008 2
2009 3
2010 2
2012 2
2013 1
2014 4
2015 4
2018 2
2019 2
2020 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Results by year

Filters applied: . Clear all
Page 1
Multidrug resistance.
Moscow JA, Cowan KH. Moscow JA, et al. Among authors: cowan kh. J Natl Cancer Inst. 1988 Mar 2;80(1):14-20. doi: 10.1093/jnci/80.1.14. J Natl Cancer Inst. 1988. PMID: 2892943 Review.
Breast cancer risk reduction.
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Seewaldt V, Sellin RV, Shapiro CL, Singletary E, Ward JH; National Comprehensive Cancer Network (NCCN). Bevers TB, et al. Among authors: cowan kh. J Natl Compr Canc Netw. 2007 Sep;5(8):676-701. J Natl Compr Canc Netw. 2007. PMID: 17927926 No abstract available.
Glutathione S-transferase and drug resistance.
Cazenave LA, Moscow JA, Myers CE, Cowan KH. Cazenave LA, et al. Among authors: cowan kh. Cancer Treat Res. 1989;48:171-87. doi: 10.1007/978-1-4613-1601-5_11. Cancer Treat Res. 1989. PMID: 2577137 Review.
The pharmacology and clinical use of methotrexate.
Jolivet J, Cowan KH, Curt GA, Clendeninn NJ, Chabner BA. Jolivet J, et al. Among authors: cowan kh. N Engl J Med. 1983 Nov 3;309(18):1094-104. doi: 10.1056/NEJM198311033091805. N Engl J Med. 1983. PMID: 6353235 Review. No abstract available.
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
Tarullo SE, He Y, Daughters C, Knutson TP, Henzler CM, Price MA, Shanley R, Witschen P, Tolg C, Kaspar RE, Hallstrom C, Gittsovich L, Sulciner ML, Zhang X, Forster CL, Lange CA, Shats O, Desler M, Cowan KH, Yee D, Schwertfeger KL, Turley EA, McCarthy JB, Nelson AC. Tarullo SE, et al. Among authors: cowan kh. J Pathol. 2023 Jul;260(3):289-303. doi: 10.1002/path.6082. Epub 2023 Apr 26. J Pathol. 2023. PMID: 37186300 Free PMC article.
Breast cancer risk reduction.
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, Mahoney MC, Merajver SD, Meszoely I, Newman L, Pritchard E, Seewaldt V, Sellin RV, Shapiro CL, Ward JH. Bevers TB, et al. Among authors: cowan kh. J Natl Compr Canc Netw. 2010 Oct;8(10):1112-46. doi: 10.6004/jnccn.2010.0083. J Natl Compr Canc Netw. 2010. PMID: 20971838 No abstract available.
Multidrug resistance.
Schneider E, Paul D, Ivy P, Cowan KH. Schneider E, et al. Among authors: cowan kh. Cancer Chemother Biol Response Modif. 1999;18:152-77. Cancer Chemother Biol Response Modif. 1999. PMID: 10800482 Review. No abstract available.
Antineoplastic drug resistance and breast cancer.
Morrow CS, Cowan KH. Morrow CS, et al. Among authors: cowan kh. Ann N Y Acad Sci. 1993 Nov 30;698:289-312. doi: 10.1111/j.1749-6632.1993.tb17220.x. Ann N Y Acad Sci. 1993. PMID: 7904140 Review. No abstract available.
189 results